Review of The Outcomes of COVID-19 Patients with Spontaneous Intracerebral Hemorrhage Comorbidity and the Efficacy of Enoxaparin in Decreasing the Mortality Rate in Them: Single Egyptian Center Report

Pre-publication Review of

The Outcomes of COVID-19 Patients with Spontaneous Intracerebral Hemorrhage Comorbidity and the Efficacy of Enoxaparin in Decreasing the Mortality Rate in Them: Single Egyptian Center Report

Reviewed On September 15, 2022 , and October 27, 2022

Verified

Submitted to

Reviewed by

Actions

Reviewed on September 15, 2022

Source

Reviewed on October 27, 2022

Source

References

Mohamed, S., O., E. M., M., F. A., Mahmoud, K. D., O., E. A., M., M. T., A., A. M. E. 2022. The Outcomes of COVID-19 Patients with Spontaneous Intracerebral Hemorrhage Comorbidity and the Efficacy of Enoxaparin in Decreasing the Mortality Rate in Them: Single Egyptian Center Report. Journal of Personalized Medicine.